In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license.
Dr. Paul Michaels, Director of the Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.
In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license to “purified, recombinant, catalytically inactive botulinum neurotoxin holoproteins (ciBoNT) representing serotypes A-F produced in transgenic strains of the methylotrophic yeast Pichia pastoris, and Pichia pastoris cell lines expressing the same ciBoNTs, in their capacity as producers of the ciBoNTs only” to Mapp Biopharmaceutical, Inc., having its principal place of business at 6160 Lusk Blvd. # C200, San Diego, CA 92121.
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see ADDRESSES).